Minocycline Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 72789-523

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Minocycline Hydrochloride (NDC 72789-523). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (72789523)

Minocycline Hydrochloride Extended-Release Tablets USP 45 mg film coated, 30 count prescription medication label. The product is marketed and packaged by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK, and manufactured by Alkem Laboratories LTD., Mumbai, India. The label includes storage instructions and a barcode.*

FDA Label Image

Image (72789524)

Packaging label for Minocycline Hydrochloride Extended-Release Tablets USP, 65 mg. The label indicates a film-coated, extended-release tablet formulation with a package size of 30 tablets. It is labeled for prescription use only (Rx Only) and marketed and packaged by PD-Rx Pharmaceuticals, Inc. The label also notes storage instructions and manufacturing details by Alkem Laboratories LTD, Mumbai, India.*

FDA Label Image

Image (72789526)

Minocycline Hydrochloride Extended-Release 55 mg film-coated tablets label for a 30-count prescription package. The label shows the branding, dosage strength, and dosage form. It is marketed and packaged by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK, and manufactured by Alkem Laboratories LTD., Mumbai, India. Storage instructions and regulatory barcodes are also visible.*

FDA Label Image

Image (72789527)

Label for Minocycline Hydrochloride extended-release tablets, USP, 80 mg strength. The label indicates a prescription-only oral tablet dosage form containing 30 tablets per container. Marketed and packaged by PD-Rx Pharmaceuticals, Inc., and manufactured by Alkem Laboratories Ltd. Storage instructions and regulatory information are included on the label.*

FDA Label Image

Image (72789528)

Label for Minocycline Hydrochloride Extended-Release Tablets, USP 105 mg, film-coated, oral dosage form. The package contains 30 tablets and is marked Rx Only. Marketed and packaged by PD-Rx Pharmaceuticals, Inc., with manufacturing by Alkem Laboratories LTD., India. The label includes storage instructions and regulatory information.*

FDA Label Image

Image (72789529)

Minocycline Hydrochloride Extended-Release Tablets USP 115 mg film coated tablets in a package of 30 tablets. Label indicates Rx only, marketed and packaged by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK, and manufactured by Alkem Laboratories Ltd., Mumbai, India. Contains storage and dispensing instructions along with barcode and QR codes for prescribing information.*

FDA Label Image

Image (72789530)

Minocycline Hydrochloride Extended-Release Tablets USP, 135 mg, film-coated, oral dosage form. The prescription bottle label indicates a quantity of 30 tablets. Marketed and packaged by PD-Rx Pharmaceuticals, Inc. and manufactured by Alkem Laboratories LTD., Mumbai, India. The label includes storage instructions and dosage information references.*

FDA Label Image

Mino-struc (Mino Structures)

Chemical structure of Minocycline Hydrochloride showing the molecular arrangement including multiple hydroxyl groups, amide group, and dimethylamine groups with the hydrochloride component indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.